Project Details
| Short title | Targeting the ATM-CHK2 pathway as a therapeutic avenue for rare neurodegenerative diseases |
|---|---|
| Status | Finished |
| Effective start/end date | 1/02/23 → 30/09/25 |
Funding
- LifeArc
Targeting the ATM-CHK2 pathway as a therapeutic avenue for rare neurodegenerative diseases
- Beggs, Andrew (Co-Investigator)
- Tuxworth, Richard (Principal Investigator)
- Bardella, Chiara (Co-Investigator)
- Ahmed, Zubair (Co-Investigator)